SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $4,183,000 | -12.0% | 373,523 | -13.5% | 0.61% | +8.7% |
Q2 2017 | $4,752,000 | +22.3% | 431,996 | +9.0% | 0.56% | +48.0% |
Q1 2017 | $3,884,000 | +87.8% | 396,336 | +107.0% | 0.38% | +120.2% |
Q4 2016 | $2,068,000 | +0.8% | 191,474 | -4.3% | 0.17% | -11.7% |
Q3 2016 | $2,052,000 | +6.3% | 200,170 | +35.5% | 0.20% | -26.0% |
Q2 2016 | $1,930,000 | +90.0% | 147,772 | +60.0% | 0.26% | +90.6% |
Q1 2016 | $1,016,000 | +29.1% | 92,356 | +8.0% | 0.14% | +39.0% |
Q4 2015 | $787,000 | +1.3% | 85,541 | -23.6% | 0.10% | -18.7% |
Q3 2015 | $777,000 | -45.7% | 111,985 | -23.2% | 0.12% | -47.4% |
Q2 2015 | $1,432,000 | +137.5% | 145,821 | +114.4% | 0.23% | +200.0% |
Q1 2015 | $603,000 | -68.5% | 68,007 | -75.5% | 0.08% | -75.2% |
Q3 2014 | $1,915,000 | +1350.8% | 277,968 | +856.3% | 0.32% | +707.7% |
Q1 2014 | $132,000 | +57.1% | 29,068 | +75.4% | 0.04% | +11.4% |
Q4 2013 | $84,000 | -25.0% | 16,568 | -24.9% | 0.04% | -38.6% |
Q3 2013 | $112,000 | +8.7% | 22,052 | +6.3% | 0.06% | -13.6% |
Q2 2013 | $103,000 | – | 20,752 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |